Just too much unknown and unfinished at this point
Post# of 36537
(Total Views: 281)
Posted On: 01/14/2020 11:22:12 AM
Just too much unknown and unfinished at this point.
Sometimes things get to a point many investors won't buy a certain stock anymore. Generex had a bad reputation from before Joe became CEO. Investors gave him the benefit of the doubt based on dangling multiple dividends, up listing GNBT and spinning NGIO carrots. Huge revenue from the MSO was expected to make all this viable.
Then you have what happened with Veneto MSO, CMF and Veneto selling shares.
Now there is bizarre price action.
My free cash is mostly going elsewhere. Not saying GNBT is dead at all but I don't blame anyone putting money to work buying small and wait for something truly positive to happen.
Sometimes things get to a point many investors won't buy a certain stock anymore. Generex had a bad reputation from before Joe became CEO. Investors gave him the benefit of the doubt based on dangling multiple dividends, up listing GNBT and spinning NGIO carrots. Huge revenue from the MSO was expected to make all this viable.
Then you have what happened with Veneto MSO, CMF and Veneto selling shares.
Now there is bizarre price action.
My free cash is mostly going elsewhere. Not saying GNBT is dead at all but I don't blame anyone putting money to work buying small and wait for something truly positive to happen.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼